Anti-SLAMF7

Anti-SLAMF7
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
E-AB-52145.20 20 µl -

7 - 16 Werktage*

71,00 €
E-AB-52145.60 60 µl -

7 - 16 Werktage*

143,00 €
E-AB-52145.120 120 µl -

7 - 16 Werktage*

238,00 €
E-AB-52145.200 200 µl -

7 - 16 Werktage*

396,00 €
 
Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM... mehr
Produktinformationen "Anti-SLAMF7"
Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Isoform1mediates NK cell activation through a SH2D1A-independent extracellular signal-regulated ERK-mediated pathway (PubMed:11698418). Positively regulates NK cell functions by a mechanism dependent on phosphorylated SH2D1B. Downstream signaling implicates PLCG1, PLCG2 and PI3K (PubMed:16339536). In addition to heterotypic NK cells-target cells interactions also homotypic interactions between NK cells may contribute to activation. However, in the absence of SH2D1B, inhibits NK cell function. Acts also inhibitory in T-cells (By similarity). May play a role in lymphocyte adhesion (PubMed:11802771). In LPS-activated monocytes negatively regulates production of proinflammatory cytokines (PubMed:23695528). Protein function: Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Isoform 1 mediates NK cell activation through a SH2D1A-independent extracellular signal-regulated ERK-mediated pathway (PubMed:11698418). Positively regulates NK cell functions by a mechanism dependent on phosphorylated SH2D1B. Downstream signaling implicates PLCG1, PLCG2 and PI3K (PubMed:16339536). In addition to heterotypic NK cells-target cells interactions also homotypic interactions between NK cells may contribute to activation. However, in the absence of SH2D1B, inhibits NK cell function. Acts also inhibitory in T-cells. May play a role in lymphocyte adhesion (PubMed:11802771). In LPS-activated monocytes negatively regulates production of proinflammatory cytokines (PubMed:23695528). [The UniProt Consortium]
Schlagworte: Anti-CS1, Anti-CRACC, Anti-CD319, Anti-SLAMF7, Anti-Novel Ly9, Anti-Protein 19A, Anti-CD2 subset 1, Anti-SLAM family member 7, Anti-Membrane protein FOAP-12, Anti-CD2-like receptor-activating cytotoxic cells, SLAMF7 Polyclonal Antibody
Hersteller: Elabscience
Hersteller-Nr: E-AB-52145

Eigenschaften

Anwendung: IHC, ELISA
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Immunogen: Fusion protein of human SLAMF7

Handhabung & Sicherheit

Lagerung: -20°C
Versand: 4°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-SLAMF7"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen